Jacobs Levy Equity Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-219,311
| Closed | -$438K | – | 1072 |
|
|
2020
Q2 | $438K | Sell |
219,311
-186,827
| -46% | -$373K | ﹤0.01% | 815 |
|
|
2020
Q1 | $792K | Buy |
406,138
+36,895
| +10% | +$71.9K | 0.01% | 681 |
|
|
2019
Q4 | $1.53M | Sell |
369,243
-215,061
| -37% | -$892K | 0.02% | 592 |
|
|
2019
Q3 | $1.76M | Buy |
584,304
+486,662
| +498% | +$1.47M | 0.02% | 538 |
|
|
2019
Q2 | $614K | Sell |
97,642
-70,123
| -42% | -$441K | 0.01% | 710 |
|
|
2019
Q1 | $933K | Sell |
167,765
-79,325
| -32% | -$441K | 0.01% | 678 |
|
|
2018
Q4 | $1.64M | Buy |
247,090
+73,760
| +43% | +$490K | 0.03% | 503 |
|
|
2018
Q3 | $1.85M | Buy |
173,330
+2,223
| +1% | +$23.7K | 0.03% | 536 |
|
|
2018
Q2 | $2.05M | Buy |
171,107
+81,463
| +91% | +$977K | 0.03% | 506 |
|
|
2018
Q1 | $768K | Sell |
89,644
-54,495
| -38% | -$467K | 0.01% | 694 |
|
|
2017
Q4 | $1.42M | Buy |
+144,139
| New | +$1.42M | 0.03% | 540 |
|
|
2015
Q3 | – | Sell |
-28,054
| Closed | -$226K | – | 844 |
|
|
2015
Q2 | $226K | Sell |
28,054
-64,143
| -70% | -$517K | ﹤0.01% | 707 |
|
|
2015
Q1 | $609K | Sell |
92,197
-68,951
| -43% | -$455K | 0.01% | 562 |
|
|
2014
Q4 | $1.03M | Buy |
+161,148
| New | +$1.03M | 0.02% | 496 |
|